Dabrafenib/Trametinib Combination Approved in BRAF-Mutant Melanoma
The FDA granted approval to the combination of dabrafenib and trametinib for the adjuvant treatment of melanoma, specifically in patients with a BRAF V600E or V600K mutation. (Source: CancerNetwork)
Source: CancerNetwork - May 9, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Melanoma SiteTerms/www.cannabissciencetech.com/News Source Type: news

Skin cancer - add this £1.50 fruit to your breakfast to prevent melanoma
SKIN cancer symptoms could be caused by getting too much sunshine in the hot weather. But, you could lower your risk of developing a melanoma by adding this cheap fruit to your diet. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Where melanoma remains a 'national cancer'
Mandy Johnson believes that she owes her life to a 90-second online test. (Source: CNN.com - Health)
Source: CNN.com - Health - May 9, 2018 Category: Consumer Health News Source Type: news

New cancer immunotherapy drugs rapidly reach patients after approval
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies are adopted at a much quicker pace than is typical for newly approved medical treatments, the researchers said. (Source: World Pharma News)
Source: World Pharma News - May 9, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Expert Panel Highlights Patient Choice for Prostate Cancer Screen
Title: Expert Panel Highlights Patient Choice for Prostate Cancer ScreenCategory: Health NewsCreated: 5/8/2018 12:00:00 AMLast Editorial Review: 5/9/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 9, 2018 Category: Cancer & Oncology Source Type: news

Judge Says Coffee Sold in California Must Carry Cancer Warnings
Title: Judge Says Coffee Sold in California Must Carry Cancer WarningsCategory: Health NewsCreated: 5/9/2018 12:00:00 AMLast Editorial Review: 5/9/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 9, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: New protein may help to catch lung cancer early
Japanese-based researchers have uncovered a biomarker that may help to diagnose lung cancer much earlier than the current tests can. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 9, 2018 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Nigeria:Foreign Hospital Seeks to Help Nigeria Defeat Cancer
[Vanguard] Abuja -A leading health care provider in the Middle East, the Saudi-German Hospital, Tuesday expressed the desire to help Nigeria win the fight against cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 9, 2018 Category: African Health Source Type: news

Multiple Myeloma With Severe Abdominal Pain and Diarrhea Multiple Myeloma With Severe Abdominal Pain and Diarrhea
In this unusual case, diarrhea and abdominal pain were the initial presenting symptoms of multiple myeloma with a plasmacytoma.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 9, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

TGen develops quality-control test for detecting cancer in blood
(The Translational Genomics Research Institute) There is vast potential in precision-medicine methods of both detecting and monitoring disease by looking for indications of cancer mutations in cell-free DNA (cfDNA), found floating in the blood. To help ensure the quality of these molecular biomarkers, a scientific team led by the Translational Genomics Research Institute (TGen) has devised a rapid test -- a droplet digital PCR (ddPCR) assay -- so these samples can be used to help determine the presence and progression of disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Two Penn clinicians among this year's Melanoma Research Foundation honorees
(University of Pennsylvania School of Medicine) The Melanoma Research Foundation (MRF) is honoring two Penn clinicians for their tireless work in caring for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Leading scientists recognized with Academy of Medical Sciences Fellowship
(Academy of Medical Sciences (UK)) The new Fellows have been elected for their outstanding contributions to biomedical and health science, leading research discoveries, and translating developments into benefits for patients and the wider society. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Genetic counseling and testing proposed for patients with the brain tumor medulloblastoma
(St. Jude Children's Research Hospital) Researchers have created the first genetic screening guidelines for medulloblastoma patients after identifying gene variations that make carriers susceptible to develop the brain tumor and possibly other cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

Drexel study: 'Non-smoking' doesn't mean smoke-free
(Drexel University) Despite decades of indoor smoking bans and restrictions, new research from Drexel University suggests the toxins we've been trying to keep out are still finding their way into the air inside. Findings by a group of environmental engineers show that third-hand smoke, the chemical residue from cigarette smoke that attaches to anything and anyone in the vicinity of a smoke cloud, can make its way into the air and circulate through buildings where no one is smoking. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Identified in a nonsmoking classroom: A new avenue for exposure to thirdhand smoke
(American Association for the Advancement of Science) Researchers measuring air in an unoccupied, nonsmoking classroom found that almost 30 percent of the tiny particles in it were associated with residue of so-called thirdhand smoke, a finding that reveals a whole new route by which people can be exposed to smoke from tobacco products. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Is teledermoscopy cost-effective in Australia for skin cancer referrals?
(JAMA Network) An analysis estimates using teledermoscopy (dermatologic care that uses information and communications technology and digital dermoscopic images) in Australia for skin cancer referrals would cost extra per case but could achieve clinical resolution faster. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

New tool predicts deadly form of rare cancer
(Brigham and Women's Hospital) A tool to accurately determine which early-stage patients are at risk of dying from mycosis fungoides and which patients are likely to only require conventional therapy is desperately needed. Investigators from Brigham and Women's Hospital have found that next-generation, high-throughput sequencing of a specific gene (T-cell receptor beta or TCRB) is a stronger predictor of which early-stage patients will develop aggressive, progressive MF than any other established factor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

New CAR T case study shows promise in acute myeloid leukemia
(H. Lee Moffitt Cancer Center& Research Institute) According to a case study from trial published online ahead of print in the journal Haematologica, a patient has remained cancer free for nine months after being treated with CYAD-01, followed by a bone marrow transplant. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Mount Sinai launches the i3 Asset Accelerator to advance the development of life-saving discoveries
(The Mount Sinai Hospital / Mount Sinai School of Medicine) The i3 Asset Accelerator is a new fund that fast-tracks select research discoveries to reach patients sooner, and has selected its first two projects to receive funding in 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Two Penn clinicians among this tear's Melanoma Research Foundation honorees
(University of Pennsylvania School of Medicine) The Melanoma Research Foundation (MRF) is honoring two Penn clinicians for their tireless work in caring for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

An AI oncologist to help cancer patients worldwide
(University of Texas at Austin, Texas Advanced Computing Center) Before performing radiation therapy, oncologists review medical images to identify tumors and surrounding tissue, a process known as contouring. Researchers from MD Anderson Cancer Center developed a new method for automating the contouring of high-risk clinical target volumes using artificial intelligence and supercomputers. They found the predicted contours could be implemented clinically, with only minor or no changes. Results appear in the June 2018 issue of the International Journal of Radiation Oncology*Biology*Physics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

New fund to advance commercialization at University of Utah
(University of Utah) The Center for Technology& Venture Commercialization at the U announced a new funding program for early stage technology development and commercialization. The University of Utah Seed Fund will allocate up to $1 million, focused on technologies at an early stage of development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Study may help explain racial disparities in prostate cancer
(Wiley) New research published in Molecular Oncology may help explain why African American men are at a higher risk of being diagnosed with prostate cancer and a higher risk of dying from the disease compared with European American men. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Operating on brain gliomas by detecting the 'glow'
(St. Joseph's Hospital and Medical Center) Research by Barrow Neurological Institute physicians and University of Washington scientists on novel imaging technology for malignant brain tumors was published in the April issue of World Neurosurgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

2018 ICIS-BioLegend William E. Paul Award for Excellence in Cytokine Research
(International Cytokine& Interferon Society) Giorgio Trinchieri, M.D., NIH, National Cancer Institute, Center for Cancer Research is the recipient of the 2018 ICIS-BioLegend William E Paul Award for Excellence in Cytokine Research in recognition of his pioneering contributions to our understanding of the role of cytokines in inflammation, immunity, and cancer. His cutting-edge research on the interface of inflammation and immunity will continue to provide knowledge that will translate basic science discoveries to clinical therapeutics. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 9, 2018 Category: Biology Source Type: news

Unlocking cancer's secrets using the 'social networks' of cells
(University of Arizona Health Sciences) Megha Padi, PhD, of the UA Cancer Center has developed a method for probing the genetic underpinnings of cancer and other diseases, which could lead to better treatments. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

HPV jab safe and effective, study finds
Trials show the vaccine is low risk and protects girls and young women against a virus linked to cervical cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 9, 2018 Category: Consumer Health News Source Type: news

Simple Post-Surgery Step Reduces Bladder Cancer Recurrence
Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study led by Edward M. Messing, M.D., and an international clinical trials network funded by the National Cancer Institute. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - May 9, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

New recommendations for prostate cancer screening
A task force has formalized its recommendations regarding the prostate cancer screening. (Source: ABC News: Health)
Source: ABC News: Health - May 9, 2018 Category: Consumer Health News Tags: Health Source Type: news

Media coverage of new Cochrane Review on HPV vaccine for cervical cancer prevention in girls and women
New evidencepublished today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials. Below is a round-up for some of the media coverage.  " HPV vaccines prevent cervical cancer, global review confirms " on CNN" HPV jab safe and effective, studies finds "on BBC Health" Major review backs cervica cancer shots, especially for teens " on Business Insider" Does H...
Source: Cochrane News and Events - May 9, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Psychological interventions have benefits for chronic pain
Benefits are small but significant in treating chronic non-cancer pain in adults, analysis shows Related items fromOnMedica Cold water plunge stopped prolonged pain Low back pain often wrongly treated worldwide Does evidence support doctors recommending acupuncture for pain? NSAIDs no better than placebo for spinal pain (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 9, 2018 Category: UK Health Source Type: news

High-intensity interval training beneficial after testicular cancer
Simple HIIT intervention reduced tiredness and improved self-esteem in testicular cancer survivors Related items fromOnMedica Exercise and psychological treatments cut cancer fatigue Preoperative exercise halves lung cancer complication rate A clinical review of testicular tumours Urgent action needed on men ’s reproductive health Inherited genetic faults blamed for almost half of testicular cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 9, 2018 Category: UK Health Source Type: news

US calls for benefits vs harms discussion before prostate cancer screening
USPSTF recommends not screening men who do not express a preference for it, or those of 70 and older Related items fromOnMedica Genetic risk model could guide prostate cancer screening Prostate cancer screening times set to be slashed One-off PSA test doesn ’t save lives, finds largest study of its kind Nearly four in ten prostate cancers 'diagnosed late' Prime minister announces £75 million to fund prostate cancer research (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 9, 2018 Category: UK Health Source Type: news

USPSTF: Decision to Undergo PSA Screening Should Be Individual
C recommendation for men aged 55 to 69 years; USPSTF recommends against screening for age 70 + (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 9, 2018 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Internal Medicine, Nursing, Oncology, Pathology, Urology, Journal, Source Type: news

Expert Panel Highlights Patient Choice for Prostate Cancer Screen
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Major review backs cervical cancer shots, especially for teens
(Reuters) - Vaccines designed to prevent infection with human papillomavirus (HPV) are effective in protecting against pre-cancerous cervical lesions in women, particularly in those vaccinated between age 15 and 26, according to a large international evidence review. (Source: Reuters: Health)
Source: Reuters: Health - May 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Major study confirms HPV vaccines prevent cervical cancer
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report finds. (Source: CNN.com - Health)
Source: CNN.com - Health - May 8, 2018 Category: Consumer Health News Source Type: news

HPV vaccines prevent cervical cancer, global review confirms
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report finds. (Source: CNN.com - Health)
Source: CNN.com - Health - May 8, 2018 Category: Consumer Health News Source Type: news

A Yellow Light, but Little Guidance, on PSA Tests
New report says prostate cancer screening may make sense for some men between the ages of 55 and 69, including those at higher than average risk because of a family history of prostate or related cancers or because they are African American (Source: WebMD Health)
Source: WebMD Health - May 8, 2018 Category: Consumer Health News Source Type: news

Cancer warnings to be served up with coffee in California
LOS ANGELES (Reuters) - Starbucks Corp and other roasters and retailers must serve up a cancer warning with coffee sold in California, a Los Angeles judge has ruled. (Source: Reuters: Health)
Source: Reuters: Health - May 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

CAR T-Cell Tx Tisagenlecleucel Approved for DLBCL
The approval includes adults with R/R DLBCL after two or more lines of prior systemic therapy, high-grade B-cell lymphoma, and DLBCL arising from FL. (Source: CancerNetwork)
Source: CancerNetwork - May 8, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Diffuse Large B-Cell Lymphoma Hematologic Malignancies News Source Type: news

Lab Study Shows HER2 Inhibitor Lapatinib Can Induce Cell Proliferation
A laboratory study has found that the HER2 inhibitor lapatinib used to slow HER2-positive breast cancer can actually induce tumor growth in some circumstances. (Source: CancerNetwork)
Source: CancerNetwork - May 8, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Where melanoma is a 'national cancer'
Mandy Johnson believes that she owes her life to a 90-second online test. (Source: CNN.com - Health)
Source: CNN.com - Health - May 8, 2018 Category: Consumer Health News Source Type: news

Prostate screening an individual decision for men over 55, panel says
A preventive screening task force revised its prostate cancer screening guidelines -- an individual decision for men 55-69 and not recommending older than 70. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 8, 2018 Category: Consumer Health News Source Type: news

Coffee roasters and retailers must put cancer warnings, Calif. judge rules
Coffee roasters will have to include a warning under a state law that requires warnings on products and in places where chemicals that can cause cancer are present. (Source: CBC | Health)
Source: CBC | Health - May 8, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

How KU Cancer Center landed trial for Novartis' cancer gene therapy
Dr. Roy Jensen, director of the University of Kansas Cancer Center, explains how the hospital's ability to attract immunotherapy trials traced back to a decision 11 years ago. The subsequent buildout of its clinical research infrastructure gave it access to Novartis' trial of Kymriah. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 8, 2018 Category: Biotechnology Authors: Elise Reuter Source Type: news

How KU Cancer Center landed trial for Novartis' cancer gene therapy
Dr. Roy Jensen, director of the University of Kansas Cancer Center, explains how the hospital's ability to attract immunotherapy trials traced back to a decision 11 years ago. The subsequent buildout of its clinical research infrastructure gave it access to Novartis' trial of Kymriah. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 8, 2018 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

California judge finalizes ruling on coffee cancer warnings
LOS ANGELES (Reuters) - A Los Angeles judge has finalized a ruling that Starbucks Corp and other coffee sellers must serve up a cancer warning with coffee sold in California. (Source: Reuters: Health)
Source: Reuters: Health - May 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Panel issues new guidelines for prostate cancer screening
The updated guidance for men ages 55 to 69 could result in more screening tests (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 8, 2018 Category: Consumer Health News Source Type: news

Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence
TUESDAY, May 8, 2018 -- Immediate post-resection intravesical installation of gemcitabine is associated with reduced recurrence over four years for patients with suspected low-grade non-muscle-invasive urothelial cancer, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news